Balance Sheet Waters Corporation

Stocks

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			5-day change	1st Jan Change
355.53 ^USD	-1.17%		-2.69%	-6.40%

11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
08/06	Waters Corporation Launches BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns	CI

8eb71894ae2a9.DBvZ__J3w01AmuRdWVHPyT7T1x_UZGbIkTiMB4Co1oA.Xzawht8buxo1_q1oIzaNvA2glni9LFG4y3zEKsvgsuNeV-mQuQKJdBLRpQ

Published financial data: WATERS CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	278.59Cr	297.2Cr	295.64Cr	295.84Cr	316.53Cr
Total Revenues	278.59Cr	297.2Cr	295.64Cr	295.84Cr	316.53Cr
Cost of Goods Sold, Total	115.65Cr	124.82Cr	119.52Cr	120.02Cr	128.88Cr
Gross Profit	162.93Cr	172.38Cr	176.12Cr	175.82Cr	187.65Cr
Selling General & Admin Expenses, Total	63Cr	66Cr	70Cr	69Cr	75Cr
R&D Expenses	17Cr	18Cr	17Cr	18Cr	20Cr
Amortization of Goodwill and Intangible Assets - (IS)	71.43L	63.66L	3.26Cr	4.71Cr	4.78Cr
Other Operating Expenses, Total	80Cr	84Cr	90Cr	92Cr	99Cr
Operating Income	83Cr	88Cr	86Cr	84Cr	89Cr
Interest Expense, Total	-4.49Cr	-4.88Cr	-9.89Cr	-8.97Cr	-6.95Cr
Interest And Investment Income	1.22Cr	1.1Cr	1.66Cr	1.74Cr	1.88Cr
Net Interest Expenses	-3.27Cr	-3.78Cr	-8.22Cr	-7.23Cr	-5.08Cr
Other Non Operating Income (Expenses)	-26.7L	8L	11.37L	11.71L	28.38L
EBT, Excl. Unusual Items	79Cr	85Cr	78Cr	77Cr	84Cr
Restructuring Charges	-	-	-2.6Cr	-	-
Merger & Related Restructuring Charges	-	-	-1.3Cr	-	-8.5Cr
Gain (Loss) On Sale Of Investments	1Cr	10L	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-97.97L	-	-	-
Legal Settlements	48.35L	-	-	-1.16Cr	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	81Cr	84Cr	74Cr	75Cr	75Cr
Income Tax Expense	11Cr	13Cr	9.4Cr	12Cr	11Cr
Earnings From Continuing Operations	69Cr	71Cr	64Cr	64Cr	64Cr
Net Income to Company	69Cr	71Cr	64Cr	64Cr	64Cr
Net Income - (IS)	69Cr	71Cr	64Cr	64Cr	64Cr
Net Income to Common Incl Extra Items	69Cr	71Cr	64Cr	64Cr	64Cr
Net Income to Common Excl. Extra Items	69Cr	71Cr	64Cr	64Cr	64Cr
Per Share Items
Net EPS - Basic	11.25	11.8	10.87	10.75	10.8
Basic EPS - Continuing Operations	11.25	11.8	10.87	10.75	10.8
Basic Weighted Average Shares Outstanding	6.16Cr	6Cr	5.91Cr	5.93Cr	5.95Cr
Net EPS - Diluted	11.17	11.73	10.84	10.71	10.76
Diluted EPS - Continuing Operations	11.17	11.73	10.84	10.71	10.76
Diluted Weighted Average Shares Outstanding	6.2Cr	6.03Cr	5.93Cr	5.96Cr	5.97Cr
Normalized Basic EPS	8.03	8.82	8.2	8.07	8.82
Normalized Diluted EPS	7.97	8.77	8.17	8.04	8.79
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	96Cr	101.41Cr	102.23Cr	102.94Cr	109.4Cr
EBITA	89Cr	94Cr	94Cr	94Cr	100.59Cr
EBIT	83Cr	88Cr	86Cr	84Cr	89Cr
EBITDAR	99Cr	105.01Cr	106.03Cr	106.84Cr	113.5Cr
Total Revenues (As Reported)	278.59Cr	297.2Cr	295.64Cr	295.84Cr	316.53Cr
Effective Tax Rate - (Ratio)	14.06	15.53	12.77	15.5	14.87
Current Domestic Taxes	2Cr	7.02Cr	66.05L	2.7Cr	1.38Cr
Current Foreign Taxes	7.67Cr	9.19Cr	8.86Cr	9.09Cr	11Cr
Total Current Taxes	9.67Cr	16Cr	9.52Cr	12Cr	13Cr
Deferred Domestic Taxes	1.08Cr	-3.1Cr	-54.86L	-80T	-1.91Cr
Deferred Foreign Taxes	57.97L	-10.17L	42.89L	-8L	44.6L
Total Deferred Taxes	1.66Cr	-3.2Cr	-11.97L	-9L	-1.47Cr
Normalized Net Income	49Cr	53Cr	48Cr	48Cr	52Cr
Non-Cash Pension Expense	6L	-19T	65T	2L	-4L
Supplemental Operating Expense Items
Advertising Expense	70L	70L	70L	60L	-
Selling and Marketing Expenses	70L	70L	70L	60L	-
Research And Development Expense From Footnotes	17Cr	19Cr	17Cr	18Cr	20Cr
Net Rental Expense, Total	3.4Cr	3.6Cr	3.8Cr	3.9Cr	4.1Cr
Imputed Operating Lease Interest Expense	78.75L	85.82L	1.46Cr	1.34Cr	1.41Cr
Imputed Operating Lease Depreciation	2.61Cr	2.74Cr	2.34Cr	2.56Cr	2.69Cr
Stock-Based Comp., COGS (Total)	25L	34.98L	20.14L	25.87L	35.39L
Stock-Based Comp., R&D Exp. (Total)	56.91L	68.74L	38.42L	59.62L	78.46L
Stock-Based Comp., SG&A Exp. (Total)	2.17Cr	3.22Cr	3.1Cr	3.62Cr	4.27Cr
Total Stock-Based Compensation	2.99Cr	4.26Cr	3.69Cr	4.47Cr	5.41Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	50Cr	48Cr	40Cr	32Cr	59Cr
Short Term Investments	6.81Cr	9L	9L	9L	-
Total Cash And Short Term Investments	57Cr	48Cr	40Cr	33Cr	59Cr
Accounts Receivable, Total	61Cr	72Cr	70Cr	73Cr	83Cr
Total Receivables	61Cr	72Cr	70Cr	73Cr	83Cr
Inventory	36Cr	46Cr	52Cr	48Cr	57Cr
Other Current Assets, Total	9.09Cr	10Cr	14Cr	13Cr	16Cr
Total Current Assets	162.89Cr	176.39Cr	175.29Cr	166.91Cr	214.76Cr
Gross Property Plant And Equipment	130.62Cr	137.08Cr	147.58Cr	145.49Cr	156.31Cr
Accumulated Depreciation	-67Cr	-70Cr	-75Cr	-73Cr	-84Cr
Net Property Plant And Equipment	63Cr	67Cr	72Cr	73Cr	72Cr
Long-term Investments	-	1.92Cr	48.35L	2.67Cr	4L
Goodwill	44Cr	43Cr	130.54Cr	129.57Cr	134.01Cr
Other Intangibles, Total	24Cr	23Cr	63Cr	57Cr	56Cr
Other Long-Term Assets, Total	15Cr	17Cr	21Cr	27Cr	31Cr
Total Assets	309.49Cr	328.15Cr	462.69Cr	455.38Cr	507.66Cr
Liabilities
Accounts Payable, Total	9.68Cr	9.33Cr	8.47Cr	9.99Cr	10Cr
Accrued Expenses, Total	10Cr	10Cr	6.94Cr	9.4Cr	9.97Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	5Cr	5Cr	-	46Cr
Current Portion of Leases	2.79Cr	2.64Cr	2.78Cr	2.55Cr	3.11Cr
Current Income Taxes Payable	6.13Cr	13Cr	12Cr	16Cr	3.55Cr
Unearned Revenue Current, Total	23Cr	23Cr	26Cr	25Cr	27Cr
Other Current Liabilities	17Cr	15Cr	18Cr	16Cr	24Cr
Total Current Liabilities	68Cr	79Cr	79Cr	79Cr	123.95Cr
Long-Term Debt	151.92Cr	152.97Cr	231.89Cr	162.71Cr	100.03Cr
Long-Term Leases	5.96Cr	6.21Cr	5.89Cr	5.03Cr	5.25Cr
Unearned Revenue Non Current	4.6Cr	5.7Cr	-	6.92Cr	-
Pension & Other Post Retirement Benefits	6.4Cr	3.82Cr	4.76Cr	4.46Cr	4.39Cr
Other Non Current Liabilities	36Cr	30Cr	26Cr	14Cr	18Cr
Total Liabilities	272.74Cr	277.7Cr	347.65Cr	272.53Cr	251.53Cr
Common Stock, Total	16.21L	16.24L	16.27L	16.3L	16.32L
Additional Paid In Capital	211.49Cr	219.98Cr	226.63Cr	234.13Cr	241.62Cr
Retained Earnings	780.08Cr	850.86Cr	915.08Cr	978.87Cr	1.04TCr
Treasury Stock	-943.79Cr	-1.01TCr	-1.01TCr	-1.01TCr	-1.02TCr
Comprehensive Income and Other	-11Cr	-14Cr	-13Cr	-16Cr	-13Cr
Total Common Equity	37Cr	50Cr	115.03Cr	182.85Cr	256.12Cr
Total Equity	37Cr	50Cr	115.03Cr	182.85Cr	256.12Cr
Total Liabilities And Equity	309.49Cr	328.15Cr	462.69Cr	455.38Cr	507.66Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6.05Cr	5.89Cr	5.92Cr	5.94Cr	9.81Cr
ECS Total Common Shares Outstanding	6.07Cr	5.91Cr	5.92Cr	5.94Cr	5.95Cr
Book Value / Share	6.05	8.54	19.44	30.79	43.01
Tangible Book Value	-31Cr	-15Cr	-78Cr	-3.51Cr	66Cr
Tangible Book Value Per Share	-5.15	-2.59	-13.25	-0.59	11.13
Total Debt	160.68Cr	166.82Cr	245.56Cr	170.3Cr	154.4Cr
Net Debt	103.75Cr	118.68Cr	205.97Cr	137.76Cr	96Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.58Cr	-36.72L	58.04L	31.31L	-4L
Debt Equivalent Oper. Leases	27Cr	29Cr	30Cr	31Cr	33Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	17Cr	21Cr	23Cr	23Cr	23Cr
Inventories - Work In Process, Total	1.97Cr	1.99Cr	2.02Cr	2.18Cr	2.82Cr
Inventories - Finished Goods, Total	17Cr	23Cr	26Cr	23Cr	31Cr
Land - (BS)	3.64Cr	3.47Cr	3.56Cr	4.09Cr	4.38Cr
Buildings, Total	45Cr	44Cr	49Cr	55Cr	57Cr
Machinery, Total	62Cr	64Cr	75Cr	75Cr	82Cr
Full Time Employees	7.8T	8.2T	7.9T	7.6T	7.9T
Accumulated Allowance for Doubtful Accounts (Supple)	1.32Cr	1.43Cr	1.93Cr	1.43Cr	1.21Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	69Cr	71Cr	64Cr	64Cr	64Cr
Depreciation & Amortization - CF	7.16Cr	7.2Cr	8.46Cr	8.7Cr	8.81Cr
Amortization of Goodwill and Intangible Assets - (CF)	6.01Cr	5.84Cr	8.13Cr	10Cr	12Cr
Depreciation & Amortization, Total	13Cr	13Cr	17Cr	19Cr	21Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-97.07L	-	-7L	-	-
Asset Writedown & Restructuring Costs	-	1Cr	-	-	-
Stock-Based Compensation (CF)	2.99Cr	4.26Cr	3.69Cr	4.47Cr	5.41Cr
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	1.66Cr	-3.2Cr	-11.97L	-9L	-1.71Cr
Change In Accounts Receivable	-6.24Cr	-14Cr	4.92Cr	-6.62Cr	-5.55Cr
Change In Inventories	-6.72Cr	-10Cr	-4.54Cr	2.09Cr	-6.59Cr
Change In Accounts Payable	4.61Cr	6.1Cr	-7.95Cr	6.16Cr	-8.9Cr
Change in Unearned Revenues	3.78Cr	1.29Cr	1.04Cr	61.65L	10L
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-6.84Cr	-8.12Cr	-17Cr	-13Cr	-2.39Cr
Cash from Operations	75Cr	61Cr	60Cr	76Cr	65Cr
Capital Expenditure	-16Cr	-18Cr	-16Cr	-14Cr	-11Cr
Sale of Property, Plant, and Equipment	-	-	-	-	28.4L
Cash Acquisitions	-	-	-128.24Cr	-	-3.51Cr
Sale (Purchase) of Intangible assets	-70L	-75.35L	-	-	-
Investment in Marketable and Equity Securities, Total	-6.34Cr	7.55Cr	7L	-15.42L	-72.95L
Cash from Investing	-23Cr	-11Cr	-144.23Cr	-14Cr	-15Cr
Long-Term Debt Issued, Total	51Cr	20Cr	145Cr	17Cr	7Cr
Total Debt Issued	51Cr	20Cr	145Cr	17Cr	7Cr
Long-Term Debt Repaid, Total	-35Cr	-14Cr	-67Cr	-90Cr	-29Cr
Total Debt Repaid	-35Cr	-14Cr	-67Cr	-90Cr	-29Cr
Issuance of Common Stock	5.56Cr	4.28Cr	2.98Cr	3.04Cr	2.08Cr
Repurchase of Common Stock	-65Cr	-63Cr	-7.03Cr	-1.35Cr	-1.47Cr
Other Financing Activities, Total	-49.88L	1.36Cr	1.54Cr	1.65Cr	-2.33Cr
Cash from Financing	-44Cr	-51Cr	75Cr	-70Cr	-24Cr
Foreign Exchange Rate Adjustments	-1.28Cr	-1.48Cr	-9L	79.2L	-6L
Net Change in Cash	6.45Cr	-2.07Cr	-8.55Cr	-7.07Cr	26Cr
Supplemental Items
Cash Interest Paid	4.24Cr	4.81Cr	9.41Cr	9.21Cr	4.46Cr
Cash Income Tax Paid (Refund)	15Cr	16Cr	24Cr	18Cr	24Cr
Levered Free Cash Flow	41Cr	35Cr	44Cr	63Cr	43Cr
Unlevered Free Cash Flow	43Cr	38Cr	51Cr	68Cr	47Cr
Change In Net Working Capital	7.64Cr	17Cr	7.19Cr	-6.56Cr	23Cr
Net Debt Issued / Repaid	16Cr	6Cr	78Cr	-73Cr	-22Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	17.41	17.32	13.54	11.4	11.52
Return on Total Capital	27.9	26.64	18.52	14.66	14.53
Return On Equity %	231.06	162.32	77.62	42.82	29.28
Return on Common Equity	231.06	162.32	77.62	42.82	29.28
Margin Analysis
Gross Profit Margin %	58.49	58	59.57	59.43	59.28
SG&A Margin	22.51	22.13	23.59	23.34	23.54
EBITDA Margin %	34.4	34.12	34.58	34.79	34.56
EBITA Margin %	31.83	31.7	31.71	31.85	31.78
EBIT Margin %	29.68	29.73	28.97	28.31	28.05
Income From Continuing Operations Margin %	24.87	23.81	21.72	21.56	20.3
Net Income Margin %	24.87	23.81	21.72	21.56	20.3
Net Avail. For Common Margin %	24.87	23.81	21.72	21.56	20.3
Normalized Net Income Margin	17.75	17.8	16.39	16.19	16.58
Levered Free Cash Flow Margin	14.56	11.61	15.01	21.2	13.5
Unlevered Free Cash Flow Margin	15.57	12.64	17.1	23.09	14.87
Asset Turnover
Asset Turnover	0.94	0.93	0.75	0.64	0.66
Fixed Assets Turnover	4.57	4.57	4.25	4.08	4.37
Receivables Turnover (Average Receivables)	4.7	4.45	4.15	4.12	4.05
Inventory Turnover (Average Inventory)	3.5	3.08	2.46	2.42	2.46
Short Term Liquidity
Current Ratio	2.39	2.24	2.22	2.11	1.73
Quick Ratio	1.74	1.53	1.39	1.34	1.14
Operating Cash Flow to Current Liabilities	1.1	0.78	0.76	0.97	0.53
Days Sales Outstanding (Average Receivables)	77.69	82.01	87.97	88.8	90.07
Days Outstanding Inventory (Average Inventory)	104.21	118.7	148.41	151.48	148.63
Average Days Payable Outstanding	25.53	25.74	25.87	29.1	26.86
Cash Conversion Cycle (Average Days)	156.37	174.97	210.51	211.18	211.84
Long Term Solvency
Total Debt/Equity	437.15	330.67	213.47	93.14	60.28
Total Debt / Total Capital	81.38	76.78	68.1	48.22	37.61
LT Debt/Equity	429.56	315.52	206.71	91.74	41.11
Long-Term Debt / Total Capital	79.97	73.26	65.94	47.5	25.65
Total Liabilities / Total Assets	88.12	84.63	75.14	59.85	49.55
EBIT / Interest Expense	18.4	18.11	8.66	9.34	12.77
EBITDA / Interest Expense	22.08	21.52	10.72	11.91	16.32
(EBITDA - Capex) / Interest Expense	18.5	17.91	9.1	10.32	14.7
Total Debt / EBITDA	1.62	1.59	2.32	1.59	1.36
Net Debt / EBITDA	1.05	1.13	1.94	1.29	0.84
Total Debt / (EBITDA - Capex)	1.93	1.91	2.73	1.84	1.51
Net Debt / (EBITDA - Capex)	1.25	1.36	2.29	1.49	0.94
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.78	6.68	-0.52	0.07	6.99
Gross Profit, 1 Yr. Growth %	19.92	5.8	2.17	-0.17	6.73
EBITDA, 1 Yr. Growth %	19.06	5.81	0.81	-1.14	4.46
EBITA, 1 Yr. Growth %	20.45	6.23	-0.47	-1.49	4.75
EBIT, 1 Yr. Growth %	21.65	6.88	-3.09	-4.32	3.77
Earnings From Cont. Operations, 1 Yr. Growth %	32.84	2.15	-9.26	-0.69	0.75
Net Income, 1 Yr. Growth %	32.84	2.15	-9.26	-0.69	0.75
Normalized Net Income, 1 Yr. Growth %	22.49	6.99	-8.43	-3.5	7.07
Diluted EPS Before Extra, 1 Yr. Growth %	33.61	5.01	-7.59	-1.2	0.47
Accounts Receivable, 1 Yr. Growth %	6.86	17.99	-2.87	4.44	13.02
Inventory, 1 Yr. Growth %	17.03	27.97	13.28	-7.55	19.93
Net Property, Plant and Equip., 1 Yr. Growth %	7.73	5.7	8.22	0.24	-0.36
Total Assets, 1 Yr. Growth %	8.98	6.03	41	-1.58	11.48
Tangible Book Value, 1 Yr. Growth %	-33.59	-51	411.81	-95.52	-1.99T
Common Equity, 1 Yr. Growth %	58.33	37.26	128.02	58.95	40.07
Cash From Operations, 1 Yr. Growth %	-5.47	-18.15	-1.45	26.43	-14.38
Capital Expenditures, 1 Yr. Growth %	-6.45	9.09	-8.69	-11.3	-20.87
Levered Free Cash Flow, 1 Yr. Growth %	-28.19	-14.89	28.53	37.66	-33.08
Unlevered Free Cash Flow, 1 Yr. Growth %	-27.17	-13.37	34.54	32.05	-32.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.59	12.09	3.02	-0.23	3.47
Gross Profit, 2 Yr. CAGR %	8.04	12.64	3.97	0.99	3.22
EBITDA, 2 Yr. CAGR %	7.97	14.17	3.28	0.75	3.15
EBITA, 2 Yr. CAGR %	7.44	15.25	2.82	0.01	3.25
EBIT, 2 Yr. CAGR %	7.4	16.36	1.77	-2.65	1.47
Earnings From Cont. Operations, 2 Yr. CAGR %	8.16	16.49	-3.72	-5.07	0.03
Net Income, 2 Yr. CAGR %	8.16	16.49	-3.72	-5.07	0.03
Normalized Net Income, 2 Yr. CAGR %	7.23	16.95	-1.02	-4.85	3.68
Diluted EPS Before Extra, 2 Yr. CAGR %	13.37	18.45	-1.49	-4.45	-0.37
Accounts Receivable, 2 Yr. CAGR %	2.1	12.29	7.06	0.72	8.65
Inventory, 2 Yr. CAGR %	5.4	22.38	20.4	2.34	5.3
Net Property, Plant and Equip., 2 Yr. CAGR %	11.3	6.71	6.95	4.15	-0.06
Total Assets, 2 Yr. CAGR %	10.02	7.49	22.27	17.8	4.75
Tangible Book Value, 2 Yr. CAGR %	-37.97	-42.95	58.37	-52.13	-8.06
Common Equity, 2 Yr. CAGR %	30.36	47.42	76.91	90.38	49.21
Cash From Operations, 2 Yr. CAGR %	7.8	-12.04	-10.18	11.62	4.04
Capital Expenditures, 2 Yr. CAGR %	-0.78	1.02	-0.2	-10	-16.22
Levered Free Cash Flow, 2 Yr. CAGR %	5.37	-20.63	4.59	34.78	-2.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.68	-19.42	7.96	34.85	-3.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.81	7.29	7.72	2.02	2.12
Gross Profit, 3 Yr. CAGR %	4.51	7.29	9.03	2.57	2.87
EBITDA, 3 Yr. CAGR %	6.22	7.25	9.53	2.41	2.56
EBITA, 3 Yr. CAGR %	6.14	7.04	9.75	2.04	2.21
EBIT, 3 Yr. CAGR %	6.15	7.23	9.48	0.43	0.16
Earnings From Cont. Operations, 3 Yr. CAGR %	5.28	6.12	7.18	-2.72	-3.17
Net Income, 3 Yr. CAGR %	5.28	6.12	7.18	-2.72	-3.17
Normalized Net Income, 3 Yr. CAGR %	5.1	7.15	7.79	-1.06	-0.27
Diluted EPS Before Extra, 3 Yr. CAGR %	13.45	10.52	9.05	-1.39	-2.84
Accounts Receivable, 3 Yr. CAGR %	2.54	7.14	6.99	6.18	4.66
Inventory, 3 Yr. CAGR %	6.89	12.44	19.27	10.25	7.89
Net Property, Plant and Equip., 3 Yr. CAGR %	22.63	9.4	7.21	4.67	2.63
Total Assets, 3 Yr. CAGR %	-6.01	8.67	17.67	13.74	15.66
Tangible Book Value, 3 Yr. CAGR %	-31.31	-42.66	18.54	-51.75	62.95
Common Equity, 3 Yr. CAGR %	-38.33	32.62	70.49	70.71	71.87
Cash From Operations, 3 Yr. CAGR %	7.33	-1.66	-8.64	0.66	2.18
Capital Expenditures, 3 Yr. CAGR %	18.84	2.4	-2.33	-4.04	-13.78
Levered Free Cash Flow, 3 Yr. CAGR %	5.76	-1.87	-6.79	15.63	7.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.13	-1.72	-4.4	16.35	7.8
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.15	5.18	4.09	4.22	6
Gross Profit, 5 Yr. CAGR %	5.01	4.82	4.29	4.72	6.67
EBITDA, 5 Yr. CAGR %	5.74	5.28	5.03	4.6	7.06
EBITA, 5 Yr. CAGR %	5.66	5.45	4.8	4.17	7.24
EBIT, 5 Yr. CAGR %	5.63	5.44	4.38	3.16	6.35
Earnings From Cont. Operations, 5 Yr. CAGR %	5.85	103.44	1.58	1.5	4.26
Net Income, 5 Yr. CAGR %	5.85	103.44	1.58	1.5	4.26
Normalized Net Income, 5 Yr. CAGR %	5.56	5.2	2.6	2.18	6.29
Diluted EPS Before Extra, 5 Yr. CAGR %	11.75	115.91	7.22	4.27	5.18
Accounts Receivable, 5 Yr. CAGR %	4.6	6.25	4.32	4.53	7.65
Inventory, 5 Yr. CAGR %	6.27	11.01	12.1	8.29	13.47
Net Property, Plant and Equip., 5 Yr. CAGR %	13.42	13.87	16.1	7.27	4.24
Total Assets, 5 Yr. CAGR %	-7.87	-9.23	4.42	12.23	12.32
Tangible Book Value, 5 Yr. CAGR %	-29.08	-37.8	-4.06	-46.65	7.08
Common Equity, 5 Yr. CAGR %	-30.71	-25.74	-6	53.26	61.64
Cash From Operations, 5 Yr. CAGR %	3.05	-2.6	-0.05	3.45	-3.76
Capital Expenditures, 5 Yr. CAGR %	11.17	15.53	10.83	-2.75	-8.14
Levered Free Cash Flow, 5 Yr. CAGR %	0.01	-7.14	5.29	11.41	-4.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.01	-6.85	6.25	11.54	-4.05